Early detection of Nasopharyngeal Carcinoma (NPC). Monitoring the effectiveness of chemotherapy or radiation. Predicting the likelihood of disease recurrence.

EBV DNA PCR Test Price | Lahalak Medical Platform

A precise quantitative PCR test measuring EBV DNA levels in the blood, essential for early detection of nasopharyngeal carcinoma and monitoring treatment efficacy to ensure the best clinical outcomes.

Scientific name: Epstein-Barr Virus (EBV) DNA Quantitative PCR

An advanced laboratory test measuring the EBV viral load. It serves as a critical diagnostic and monitoring tool for nasopharyngeal carcinoma, evaluating disease progression or recurrence risk after therapy.

Epstein-Barr Virus (EBV) DNA Quantitative PCR - Early NPC Cancer Screening Test

Service type Laboratory test

Duration 15-20 minutes

Fasting Fasting is not required

Included Services

Blood Sample Collection
Quantitative PCR Analysis
Medical Results Report

Medical Service Information

Purpose of the Test

Early detection of Nasopharyngeal Carcinoma (NPC).
Monitoring the effectiveness of chemotherapy or radiation.
Predicting the likelihood of disease recurrence.

Who Should Get Tested?

Individuals with a family history of nasopharyngeal cancer.
Patients with persistent lymphadenopathy.
Individuals with prior EBV infection showing respiratory symptoms.

Frequently Asked Questions

Does this test replace a biopsy? No, it is a complementary tool for screening and monitoring.
When will results be ready? Usually within 3 to 5 working days.